Effect of Vitamin D Supplementation on Obesity-Induced Insulin Resistance: A Double-Blind, Randomized, Placebo-Controlled Trial

Chiara M.A. Cefalo, Caterina Conte, Gian Pio Sorice, Simona Moffa, Vinsin A. Sun, Francesca Cinti, Enrica Salomone, Giovanna Muscogiuri, Alex A.G. Brocchi, Alfredo Pontecorvi, Teresa Mezza, Andrea Giaccari

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Objective: The aim was to investigate whether vitamin D supplementation, combined with a hypocaloric diet, could have an independent effect on insulin sensitivity in subjects with both overweight and hypovitaminosis D. Changes from baseline in anthropometric parameters, body composition, glucose tolerance, and insulin secretion were considered as secondary outcomes. Methods: Eighteen volunteers who were nondiabetic and vitamin D deficient and had BMI > 25 kg/m2 were randomized (1:1) in a double-blind manner to a hypocaloric diet + either oral cholecalciferol at 25,000 IU/wk or placebo for 3 months. Hyperinsulinemic-euglycemic clamp to measure insulin sensitivity was performed at baseline and after intervention. Results: Body weight in both groups decreased significantly (−7.5% in the vitamin D group and −10% in the placebo group; P < 0.05 for both), with no between-group differences. Serum 25-hydroxyvitamin D levels in the vitamin D group increased considerably (from 36.7 ± 13.2 nmol/L to 74.8 ± 18.7 nmol/L; P < 0.001). Insulin sensitivity in the vitamin D group improved (from 4.6 ± 2.0 to 6.9 ± 3.3 mg·kg−1·min−1; P < 0.001), whereas no changes were observed in the placebo group (from 4.9 ± 1.1 to 5.1 ± 0.3 mg·kg−1·min−1; P = 0.84). Conclusions: Cholecalciferol supplementation, combined with a weight loss program, significantly improves insulin sensitivity in healthy subjects with obesity and might represent a personalized approach for insulin-resistant subjects with obesity.

Original languageEnglish
Pages (from-to)651-657
Number of pages7
JournalObesity
Volume26
Issue number4
DOIs
Publication statusPublished - Apr 1 2018

Fingerprint

Vitamin D
Insulin Resistance
Randomized Controlled Trials
Obesity
Placebos
Cholecalciferol
Insulin
Diet
Weight Reduction Programs
Glucose Clamp Technique
Body Composition
Volunteers
Healthy Volunteers
Body Weight
Glucose
Serum

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Nutrition and Dietetics

Cite this

Effect of Vitamin D Supplementation on Obesity-Induced Insulin Resistance : A Double-Blind, Randomized, Placebo-Controlled Trial. / Cefalo, Chiara M.A.; Conte, Caterina; Sorice, Gian Pio; Moffa, Simona; Sun, Vinsin A.; Cinti, Francesca; Salomone, Enrica; Muscogiuri, Giovanna; Brocchi, Alex A.G.; Pontecorvi, Alfredo; Mezza, Teresa; Giaccari, Andrea.

In: Obesity, Vol. 26, No. 4, 01.04.2018, p. 651-657.

Research output: Contribution to journalArticle

Cefalo, CMA, Conte, C, Sorice, GP, Moffa, S, Sun, VA, Cinti, F, Salomone, E, Muscogiuri, G, Brocchi, AAG, Pontecorvi, A, Mezza, T & Giaccari, A 2018, 'Effect of Vitamin D Supplementation on Obesity-Induced Insulin Resistance: A Double-Blind, Randomized, Placebo-Controlled Trial', Obesity, vol. 26, no. 4, pp. 651-657. https://doi.org/10.1002/oby.22132
Cefalo, Chiara M.A. ; Conte, Caterina ; Sorice, Gian Pio ; Moffa, Simona ; Sun, Vinsin A. ; Cinti, Francesca ; Salomone, Enrica ; Muscogiuri, Giovanna ; Brocchi, Alex A.G. ; Pontecorvi, Alfredo ; Mezza, Teresa ; Giaccari, Andrea. / Effect of Vitamin D Supplementation on Obesity-Induced Insulin Resistance : A Double-Blind, Randomized, Placebo-Controlled Trial. In: Obesity. 2018 ; Vol. 26, No. 4. pp. 651-657.
@article{cb9f84b162444ed787b4530844ee8722,
title = "Effect of Vitamin D Supplementation on Obesity-Induced Insulin Resistance: A Double-Blind, Randomized, Placebo-Controlled Trial",
abstract = "Objective: The aim was to investigate whether vitamin D supplementation, combined with a hypocaloric diet, could have an independent effect on insulin sensitivity in subjects with both overweight and hypovitaminosis D. Changes from baseline in anthropometric parameters, body composition, glucose tolerance, and insulin secretion were considered as secondary outcomes. Methods: Eighteen volunteers who were nondiabetic and vitamin D deficient and had BMI > 25 kg/m2 were randomized (1:1) in a double-blind manner to a hypocaloric diet + either oral cholecalciferol at 25,000 IU/wk or placebo for 3 months. Hyperinsulinemic-euglycemic clamp to measure insulin sensitivity was performed at baseline and after intervention. Results: Body weight in both groups decreased significantly (−7.5{\%} in the vitamin D group and −10{\%} in the placebo group; P < 0.05 for both), with no between-group differences. Serum 25-hydroxyvitamin D levels in the vitamin D group increased considerably (from 36.7 ± 13.2 nmol/L to 74.8 ± 18.7 nmol/L; P < 0.001). Insulin sensitivity in the vitamin D group improved (from 4.6 ± 2.0 to 6.9 ± 3.3 mg·kg−1·min−1; P < 0.001), whereas no changes were observed in the placebo group (from 4.9 ± 1.1 to 5.1 ± 0.3 mg·kg−1·min−1; P = 0.84). Conclusions: Cholecalciferol supplementation, combined with a weight loss program, significantly improves insulin sensitivity in healthy subjects with obesity and might represent a personalized approach for insulin-resistant subjects with obesity.",
author = "Cefalo, {Chiara M.A.} and Caterina Conte and Sorice, {Gian Pio} and Simona Moffa and Sun, {Vinsin A.} and Francesca Cinti and Enrica Salomone and Giovanna Muscogiuri and Brocchi, {Alex A.G.} and Alfredo Pontecorvi and Teresa Mezza and Andrea Giaccari",
year = "2018",
month = "4",
day = "1",
doi = "10.1002/oby.22132",
language = "English",
volume = "26",
pages = "651--657",
journal = "Obesity",
issn = "1930-7381",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Effect of Vitamin D Supplementation on Obesity-Induced Insulin Resistance

T2 - A Double-Blind, Randomized, Placebo-Controlled Trial

AU - Cefalo, Chiara M.A.

AU - Conte, Caterina

AU - Sorice, Gian Pio

AU - Moffa, Simona

AU - Sun, Vinsin A.

AU - Cinti, Francesca

AU - Salomone, Enrica

AU - Muscogiuri, Giovanna

AU - Brocchi, Alex A.G.

AU - Pontecorvi, Alfredo

AU - Mezza, Teresa

AU - Giaccari, Andrea

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Objective: The aim was to investigate whether vitamin D supplementation, combined with a hypocaloric diet, could have an independent effect on insulin sensitivity in subjects with both overweight and hypovitaminosis D. Changes from baseline in anthropometric parameters, body composition, glucose tolerance, and insulin secretion were considered as secondary outcomes. Methods: Eighteen volunteers who were nondiabetic and vitamin D deficient and had BMI > 25 kg/m2 were randomized (1:1) in a double-blind manner to a hypocaloric diet + either oral cholecalciferol at 25,000 IU/wk or placebo for 3 months. Hyperinsulinemic-euglycemic clamp to measure insulin sensitivity was performed at baseline and after intervention. Results: Body weight in both groups decreased significantly (−7.5% in the vitamin D group and −10% in the placebo group; P < 0.05 for both), with no between-group differences. Serum 25-hydroxyvitamin D levels in the vitamin D group increased considerably (from 36.7 ± 13.2 nmol/L to 74.8 ± 18.7 nmol/L; P < 0.001). Insulin sensitivity in the vitamin D group improved (from 4.6 ± 2.0 to 6.9 ± 3.3 mg·kg−1·min−1; P < 0.001), whereas no changes were observed in the placebo group (from 4.9 ± 1.1 to 5.1 ± 0.3 mg·kg−1·min−1; P = 0.84). Conclusions: Cholecalciferol supplementation, combined with a weight loss program, significantly improves insulin sensitivity in healthy subjects with obesity and might represent a personalized approach for insulin-resistant subjects with obesity.

AB - Objective: The aim was to investigate whether vitamin D supplementation, combined with a hypocaloric diet, could have an independent effect on insulin sensitivity in subjects with both overweight and hypovitaminosis D. Changes from baseline in anthropometric parameters, body composition, glucose tolerance, and insulin secretion were considered as secondary outcomes. Methods: Eighteen volunteers who were nondiabetic and vitamin D deficient and had BMI > 25 kg/m2 were randomized (1:1) in a double-blind manner to a hypocaloric diet + either oral cholecalciferol at 25,000 IU/wk or placebo for 3 months. Hyperinsulinemic-euglycemic clamp to measure insulin sensitivity was performed at baseline and after intervention. Results: Body weight in both groups decreased significantly (−7.5% in the vitamin D group and −10% in the placebo group; P < 0.05 for both), with no between-group differences. Serum 25-hydroxyvitamin D levels in the vitamin D group increased considerably (from 36.7 ± 13.2 nmol/L to 74.8 ± 18.7 nmol/L; P < 0.001). Insulin sensitivity in the vitamin D group improved (from 4.6 ± 2.0 to 6.9 ± 3.3 mg·kg−1·min−1; P < 0.001), whereas no changes were observed in the placebo group (from 4.9 ± 1.1 to 5.1 ± 0.3 mg·kg−1·min−1; P = 0.84). Conclusions: Cholecalciferol supplementation, combined with a weight loss program, significantly improves insulin sensitivity in healthy subjects with obesity and might represent a personalized approach for insulin-resistant subjects with obesity.

UR - http://www.scopus.com/inward/record.url?scp=85044264314&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044264314&partnerID=8YFLogxK

U2 - 10.1002/oby.22132

DO - 10.1002/oby.22132

M3 - Article

C2 - 29504254

AN - SCOPUS:85044264314

VL - 26

SP - 651

EP - 657

JO - Obesity

JF - Obesity

SN - 1930-7381

IS - 4

ER -